mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
Vinorelbine |
GDSC1000 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |